Skip to content

Clinical trials

Completed Phase 2 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 2 Status: Completed Clear all

421 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200115
200215
200323
200423
200523
200625
200724
200827
200919
201028
201113
201213
201318
20147
201514
201615
201714
201818
20199
20209
20216
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed421

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)30
Gynecologic Oncology Group23
Memorial Sloan Kettering Cancer Center21
Eli Lilly and Company12
AstraZeneca8
ARCAGY/ GINECO GROUP7
Dana-Farber Cancer Institute7
Sanofi7
GlaxoSmithKline6
Masonic Cancer Center, University of Minnesota6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms421
Fallopian Tube Neoplasms133
Carcinoma, Ovarian Epithelial91
Neoplasms33
Breast Neoplasms28
Recurrence26
Sarcoma21
Endometrial Neoplasms20
Testicular Neoplasms20
Uterine Cervical Neoplasms16

Trials

Showing 1 to 25 of 421. Each trial links to its page on Pharma Observatory.

321 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.